Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03424993 · ClinicalTrials.gov registry record · Phase 4
Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure
A Phase 4 study, sponsored by University of Delaware.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03424993 is a Phase 4 study that has completed, run by University of Delaware. The registered enrollment target is 100 participants.
The verdict
NCT03424993, a Phase 4 study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.
Interventions
- OTHER Control
- OTHER Dietary Sodium Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-01-21 |
| Est. Completion | 2024-06-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03424993
The ClinicalTrials.gov registry entry for NCT03424993 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03424993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03424993 about?
NCT03424993 is a clinical study titled "Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure". The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.
What is the current status of trial NCT03424993?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-01-21. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT03424993?
The interventions under investigation include: Control (OTHER), Dietary Sodium Restriction (OTHER).
Who is sponsoring clinical trial NCT03424993?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.